Inventor
Daniel Cravo
Inventor
Sartrouville, FR
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
A61KPreparations for medical, dental or toiletry purposes27%
C07DHeterocyclic compounds27%
C07BGeneral methods of organic chemistry3%
C07CAcyclic or carbocyclic compounds3%
Y02ATechnologies for adaptation to climate change1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
10,071,108Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection20189,895,380'Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection'20189,365,584'Thieno [2,3-B] pyridinedione activators of AMPK and therapeutic uses thereof'20169,284,329'Thienopyridone derivatives useful as activators of AMPK'20169,271,984'Treatment of type 1 diabetes'20169,035,048'Tetrahydrotriazine compounds for treating diseases associated with AMPK activity'20158,980,828'Combination of insulin with triazine derivatives and its use for treating diabetes'20158,937,066'Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion related diseases'20158,791,115'Combination of triazine derivatives and insulin sensitisers'20148,742,102'Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization'20148,742,103'Separation of triazine derivatives enantiomers using tartaric acid'20148,674,097'Quinoxalinedione derivatives useful as activators of AMPK-activated protein kinase'20148,604,202'Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators'20138,592,370'Combination of insulin with triazine derivatives'20138,563,729'Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators'20138,420,642'Pyridine derivatives useful as glucokinase activators'20138,329,698'Quinoxalinedione derivatives which are activators of AMPK-activated protein kinase'20128,227,465'Combination of triazine derivatives and insulin secretion stimulators'20128,217,040'Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect'20127,767,676'Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses'20107,501,511'Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome'20097,491,733'Bicyclic guanidine derivatives and therapeutic uses thereof'20097,452,883'Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses'20087,285,681'Biguanide derivatives'20077,034,021'Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses'20066,518,458'(Aminoiminomethyl) amino) alkane-carboxamides and their applications in therapy'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2014Patents assigned to MERCK PATENT GMBH (9)· patent assignee history
2003–2015Based in Sartrouville, FR· patent location history
2012–2016Patents assigned to CRAVO DANIEL (15)· patent assignee history
2012–2016Patents assigned to HALLAKOU-BOZEC SOPHIE (7)· patent assignee history
2012–2016Patents assigned to LEPIFRE FRANCK (5)· patent assignee history
2012–2018Based in Montesson, FR· patent location history
2014–2018Patents assigned to POXEL (9)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CRAVO DANIELself | 15 | 2012–2016 |
| MERCK PATENT GMBH | 9 | 2003–2014 |
| POXEL | 9 | 2014–2018 |
| HALLAKOU-BOZEC SOPHIE | 7 | 2012–2016 |
| LEPIFRE FRANCK | 5 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Sartrouville, FR | 15 | 2003–2015 |
| Montesson, FR | 11 | 2012–2018 |